Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus

Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
Interventions: Drug: Rosiglitazone (Avandia) OR other diabetes medication currently prescribed to participant; Dietary Supplement: conjugated linoleic acid (CLA); Dietary Supplement: conjugated linoleic acid (CLA)
Sponsors: Ohio State University; National Center for Complementary and Integrative Health (NCCIH); GlaxoSmithKline; Bunge Loders Croklaan; LifeScan
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 11, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments